Contract development & manufacturing organization Althea, an Ajinomoto company, announced today the launch of a new, high-performance sterile vial filling line.
The Optima VFVM 7000 aseptic fill finish line adds to Althea’s drug product manufacturing capabilities and enables the company to work with larger batch sizes and a broader range of filling volumes – up to 100 milliliters, the company reported.
The new line also cuts back on product loss, preserving expensive active pharmaceutical ingredients.
“We are very pleased to announce Althea’s new Optima VFVM 7000 aseptic vial filling line. The upgraded capabilities of this line signifies Althea’s continued commitment to quality and technical excellence,” head of engineering Stacy Sutton said in prepared remarks.
“The new equipment has features which expand our drug product capabilities to maximize filling accuracy for both small and large fill volumes and deliver larger batch sizes to our clients. The Optima VFVM 7000 is a key addition to Althea’s service offerings and will enhance our ability to accommodate our clients.”
The San Diego, Calif.-based company provides cGMP drug product filling in vials and syringes and also produces microbial-derived recombinant proteins and plasmid DNA.
It also offers development services for companies looking to formulate large molecules that are delivered at high concentrations or as sustained released formulations, as well as a recombinant protein expression technology.
See the best minds in medtech live at DeviceTalks Boston on Oct. 2.
